| Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer (NCT00294151) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2005-09-01 |
| Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy (NCT00201630) | New York Prostate Institute | 2005-09-01 |
| Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy (NCT00305747) | Barbara Ann Karmanos Cancer Institute | 2005-08-01 |
| A Study of Imatinib and Docetaxel in Prostate Cancer (NCT00251225) | Leonard Appleman | 2005-08-01 |
| Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer (NCT00284752) | Kaiser Permanente | 2005-08-01 |
| Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer (NCT00225420) | UNC Lineberger Comprehensive Cancer Center | 2005-08-01 |
| Investigation of Protein Biomarkers of Prostate Cancer (NCT00323180) | University of New Mexico | 2005-08-01 |
| Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy (NCT00441532) | Corewell Health East | 2005-08-01 |
| Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer (NCT00268593) | Progen Pharmaceuticals | 2005-08-01 |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors (NCT00433407) | Jonsson Comprehensive Cancer Center | 2005-08-01 |
| Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy (NCT00148772) | Endeavor Health | 2005-08-01 |
| Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer (NCT00255606) | Tampere University | 2005-08-01 |
| Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer (NCT01378091) | Columbia University | 2005-08-01 |
| Investigation of Early Hormonotherapy Efficacy of Prostate Cancer (NCT00375687) | Kaunas University of Medicine | 2005-08-01 |
| Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer (NCT00124917) | National Cancer Institute (NCI) | 2005-07-21 |
| Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (NCT00268476) | Medical Research Council | 2005-07-08 |
| Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer (NCT00253643) | OHSU Knight Cancer Institute | 2005-07-01 |
| Positioning and Tracking the Prostate During External Beam Radiation (NCT00123838) | Varian, a Siemens Healthineers Company | 2005-07-01 |
| Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer (NCT00939510) | Robert Dreicer MD | 2005-07-01 |
| GVAX in Advanced Prostate Cancer Patients Made Lymphopenic (NCT00122005) | Providence Health & Services | 2005-07-01 |
| Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer (NCT00534196) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2005-07-01 |
| Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients (NCT00133224) | Cell Genesys | 2005-07-01 |
| A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast (NCT00147238) | M.D. Anderson Cancer Center | 2005-07-01 |
| Safety Study of Hemospan® in Prostatectomy Patients (NCT00425334) | Sangart | 2005-07-01 |
| Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer (NCT00139191) | Dana-Farber Cancer Institute | 2005-07-01 |
| Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer (NCT00134355) | University of Michigan Rogel Cancer Center | 2005-07-01 |
| Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy (NCT00578123) | Memorial Sloan Kettering Cancer Center | 2005-07-01 |
| Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer (NCT00313534) | University of California, San Francisco | 2005-06-01 |
| Use of Multiphoton Microscopy in the Diagnosis of Cancer (NCT00652210) | Weill Medical College of Cornell University | 2005-06-01 |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer (NCT00900835) | City of Hope Medical Center | 2005-06-01 |
| Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI (NCT00242112) | University Health Network, Toronto | 2005-06-01 |
| Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer (NCT00138918) | University of British Columbia | 2005-06-01 |
| Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer (NCT00116142) | Dana-Farber Cancer Institute | 2005-06-01 |
| MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer (NCT00706966) | University of California, San Francisco | 2005-06-01 |
| Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy (NCT02382094) | Karolinska University Hospital | 2005-06-01 |
| A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients (NCT00196339) | Duramed Research | 2005-06-01 |
| Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer (NCT00111618) | Antisoma Research | 2005-05-01 |
| Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer (NCT00258466) | Barbara Ann Karmanos Cancer Institute | 2005-05-01 |
| Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer (NCT00176644) | University of Medicine and Dentistry of New Jersey | 2005-05-01 |
| EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide (NCT00132522) | EMD Serono | 2005-05-01 |
| Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer (NCT00176605) | Rutgers, The State University of New Jersey | 2005-05-01 |
| Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. (NCT00258401) | Case Comprehensive Cancer Center | 2005-05-01 |
| Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017) (NCT00110188) | Merck Sharp & Dohme LLC | 2005-05-01 |
| Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer (NCT01076335) | M.D. Anderson Cancer Center | 2005-05-01 |
| Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer (NCT00861471) | NYU Langone Health | 2005-05-01 |
| Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer (NCT00183937) | University of Southern California | 2005-04-30 |
| Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer (NCT00796458) | A.O.U. San Giovanni Battista di Torino, Italy | 2005-04-01 |
| The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer (NCT00126802) | AHS Cancer Control Alberta | 2005-04-01 |
| Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer (NCT00375765) | GlaxoSmithKline | 2005-04-01 |
| Reiki/Energy Healing in Prostate Cancer (NCT00065208) | The Cleveland Clinic | 2005-04-01 |
| Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers (NCT00973882) | Centre Leon Berard | 2005-04-01 |
| A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer. (NCT00179738) | Celgene Corporation | 2005-04-01 |
| Preoperative Radiation Therapy for High Risk Prostate Cancer (NCT01041326) | Duke University | 2005-04-01 |
| Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy (NCT00127816) | AHS Cancer Control Alberta | 2005-04-01 |
| Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients (NCT00139204) | Dana-Farber Cancer Institute | 2005-04-01 |
| UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling (NCT00355758) | University of California, Irvine | 2005-04-01 |
| Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer (NCT00582140) | University of Wisconsin, Madison | 2005-03-01 |
| Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer (NCT00217516) | Roswell Park Cancer Institute | 2005-03-01 |
| Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes (NCT00214136) | University of Wisconsin, Madison | 2005-03-01 |
| Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome (NCT00167024) | National Taiwan University Hospital | 2005-03-01 |
| Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer (NCT00607932) | Vanderbilt University | 2005-03-01 |
| The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer (NCT00261456) | Institute of Cancer Research, United Kingdom | 2005-03-01 |
| Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer (NCT00117286) | Ferring Pharmaceuticals | 2005-03-01 |
| 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer (NCT00326638) | Ottawa Hospital Research Institute | 2005-03-01 |
| Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial (NCT00207259) | Brigham and Women's Hospital | 2005-03-01 |
| Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly (NCT00161252) | University of Medicine and Dentistry of New Jersey | 2005-03-01 |
| Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. (NCT00695851) | Memorial Sloan Kettering Cancer Center | 2005-03-01 |
| A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer (NCT00383487) | Stanford University | 2005-03-01 |
| A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer (NCT00777452) | Samsung Medical Center | 2005-03-01 |
| Vaccine Treatment for Hormone Refractory Prostate Cancer (NCT00105053) | NewLink Genetics Corporation | 2005-03-01 |
| Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer (NCT00115635) | Herlev Hospital | 2005-03-01 |
| Use of Tracking Devices to Locate Abnormalities During Invasive Procedures (NCT00102544) | National Institutes of Health Clinical Center (CC) | 2005-02-23 |
| A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer (NCT00780975) | PharmaMar | 2005-02-01 |
| Mifepristone (RU-486) in Androgen Independent Prostate Cancer (NCT00140478) | Dana-Farber Cancer Institute | 2005-02-01 |
| A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy (NCT00106392) | Astellas Pharma Inc | 2005-02-01 |
| Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer (NCT00199537) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2005-02-01 |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer (NCT00388804) | M.D. Anderson Cancer Center | 2005-02-01 |
| A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery (NCT00200187) | Memorial Sloan Kettering Cancer Center | 2005-02-01 |
| Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer (NCT00142506) | Memorial Sloan Kettering Cancer Center | 2005-02-01 |
| An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer (NCT00215683) | Ferring Pharmaceuticals | 2005-02-01 |
| Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer (NCT00293371) | University of California, San Francisco | 2005-02-01 |
| Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (NCT00673127) | Beth Israel Deaconess Medical Center | 2005-02-01 |
| Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer (NCT00216099) | Christopher Sweeney, MBBS | 2005-02-01 |
| Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy (NCT00554918) | University Hospital Birmingham | 2005-02-01 |
| Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting (NCT01440855) | Fox Chase Cancer Center | 2005-02-01 |
| Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer (NCT00379119) | University of California, San Francisco | 2005-01-01 |
| Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer (NCT00241384) | Schiffler Cancer Center | 2005-01-01 |
| Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy (NCT00442000) | Corewell Health East | 2005-01-01 |
| A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers (NCT00122239) | AHS Cancer Control Alberta | 2005-01-01 |
| Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy (NCT00242931) | OHSU Knight Cancer Institute | 2005-01-01 |
| Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate (NCT00632138) | Aberdeen Royal Infirmary | 2005-01-01 |
| GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer (NCT00087165) | University Health Network, Toronto | 2005-01-01 |
| A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer (NCT00116753) | Ferring Pharmaceuticals | 2005-01-01 |
| Men Undergoing Radical Prostatectomy (NCT00582530) | Memorial Sloan Kettering Cancer Center | 2004-12-28 |
| Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy (NCT00403000) | Roswell Park Cancer Institute | 2004-12-01 |
| Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening (NCT00207636) | Centers for Disease Control and Prevention | 2004-12-01 |
| Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy (NCT00133900) | Immunicon | 2004-12-01 |
| Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer (NCT00104130) | Bristol-Myers Squibb | 2004-12-01 |
| Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer (NCT00559429) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-12-01 |
| Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer (NCT00060086) | Jonsson Comprehensive Cancer Center | 2004-11-30 |